Female sex was independently associated with 0.094 log10 (or 1.24) AU/mL higher ACE2 competition activity after the first dose (P = .03), which is consistent with reports that women display higher neutralizing responses following infection and vaccination [27]. Here, ACE2 is linked to infection.